Sonnet BioTherapeutics Holdings (SONN)

Sonnet BioTherapeutics Holdings (SONN) Financial Statements


Sonnet BioTherapeutics Holdings Financial Overview

Sonnet BioTherapeutics Holdings's market cap is currently ―. The company's EPS TTM is $-6.185; its P/E ratio is -0.06; Sonnet BioTherapeutics Holdings is scheduled to report earnings on February 13, 2023, and the estimated EPS forecast is $-1.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 37.26K$ 62.75K$ 62.07K$ 95.32K$ 129.80K
Gross Profit-----
EBIT$ -5.61M$ -7.38M$ -7.87M$ -8.21M$ -6.21M
EBITDA$ -5.59M$ -7.36M$ -7.84M$ -8.18M$ -6.19M
Net Income Common Stockholders$ -5.54M$ -7.44M$ -7.88M$ -8.21M$ -6.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.70M$ 3.05M$ 5.22M$ 13.64M$ 19.41M
Total Assets$ 4.94M$ 5.83M$ 7.49M$ 15.05M$ 20.74M
Total Debt$ 238.79K$ 255.99K$ 272.68K$ 80.35K$ 103.65K
Net Debt$ -1.46M$ -2.80M$ -4.95M$ -13.56M$ -19.31M
Total Liabilities$ 8.48M$ 8.37M$ 6.73M$ 6.51M$ 4.35M
Stockholders Equity$ -3.54M$ -2.54M$ 764.21K$ 8.53M$ 16.39M
Cash Flow-
Free Cash Flow$ -5.92M$ -6.19M$ -8.41M$ -5.77M$ -8.21M
Operating Cash Flow$ -5.92M$ -6.16M$ -7.82M$ -5.61M$ -8.09M
Investing Cash Flow$ 0.00$ -24.60K$ -586.25K$ -165.63K$ -120.00K
Financing Cash Flow$ 4.56M$ 4.01M$ 0.00$ 0.00$ 0.00
Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

Sonnet BioTherapeutics Holdings Debt to Assets

Sonnet BioTherapeutics Holdings Cash Flow

Sonnet BioTherapeutics Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis